Researchers are developing a workflow for evaluating implanted biomaterials using single-cell spatial transcriptomics. This approach is part of a broader effort to apply single-cell and spatial transcriptomics to various fields, including cardiovascular and brain development research, as well as cancer studies. The use of artificial intelligence and multi-omics is also being explored in conjunction with these techniques for potential applications in drug discovery and precision medicine.